Serdolect

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Sertindole 16mg

Commercializzato da:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Nome Internazionale):

Sertindole 16 mg

Dosaggio:

16 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Sertindole 16mg Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Opadry pink 03B24027 (rose)

Confezione:

Blister pack, PVC/PVDC/Al, 20 tablets

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

Lundbeck Pharmaceuticals Italy SpA

Indicazioni terapeutiche:

Sertindole is indicated for the treatment of schizophrenia. Due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 20 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 30 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 50 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 98 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 100 tablets - 60 months from date of manufacture stored at or below 25°C

Data dell'autorizzazione:

2006-04-13